and Diclofenac: Understanding the Potential Risks of This Association

Overview

Journal Front Vet Sci

Specialty Veterinary Medicine

Date 2024 Dec 24

PMID 39717786

Authors

Bruna Lohmann-Menezes

Jeanine Giarolla

Yasmin da Silva-Santos

Giuliana Petri

Sabrina Epiphanio

Affiliations

Soon will be listed here.

Abstract

In many homes worldwide, dogs are considered part of the family. Every possible care is given to animals, including drug treatments. However, many animal guardians, in an attempt to minimize pain or improve the quality of life of their dogs, provide drugs without a veterinarian's prescription. Diclofenac, a non-steroidal anti-inflammatory drug that acts on cyclooxygenase-1 and cyclooxygenase-2 enzymes, is associated with several adverse events, especially related to the gastrointestinal tract, both in humans and pet animals. Therefore, the availability of information about the effects of this drug in different species is always essential. This narrative review aims to present adverse reactions the domestic dog () can suffer when exposed to diclofenac. Scientific publications, books, and case reports were consulted, and inquiries were also carried out with regulatory agencies. Many reports of suspected adverse reactions, especially related to the gastrointestinal tract, were found. Other clinical manifestations and lesions were also identified in the cardiovascular system, liver, kidneys, and hematological examinations. Therefore, diclofenac may constitute a hazard to dogs, mainly due to possible damage to the gastrointestinal tract. This fact reinforces the need to seek veterinary advice before providing any drug to animals, in addition to recommendations on ensuring the correct storage of medications to avoid accidental exposure.

References

Frantz L, Mullin V, Pionnier-Capitan M, Lebrasseur O, Ollivier M, Perri A . Genomic and archaeological evidence suggest a dual origin of domestic dogs. Science. 2016; 352(6290):1228-31. DOI: 10.1126/science.aaf3161. View

Baltoyiannis G, Christodoulos N, Mitsis M, Stephanou D, Ioannou H, Nousias V . A comparative experimental study of the effects of diclofenac and ketoprofen on the small-bowel mucosa of canines. Res Exp Med (Berl). 2001; 200(2):125-35. DOI: 10.1007/BF03220020. View

McNicholas J, Collis G . Dogs as catalysts for social interactions: robustness of the effect. Br J Psychol. 2000; 91 ( Pt 1):61-70. DOI: 10.1348/000712600161673. View

Kamino D, Hata J, Haruma K, Manabe N, Tanaka S, Chayama K . Real-time visualization and quantitation of canine gastric mucosal blood flow by contrast-enhanced ultrasonography. Scand J Gastroenterol. 2006; 41(7):856-61. DOI: 10.1080/00365520500464975. View

STIERLIN H, Faigle J, Sallmann A, Kung W, Richter W, Kriemler H . Biotransformation of diclofenac sodium (Voltaren) in animals and in man. I. Isolation and identification of principal metabolites. Xenobiotica. 1979; 9(10):601-10. DOI: 10.3109/00498257909042327. View

Hall N, Johnston A, Bray E, Otto C, MacLean E, Udell M . Working Dog Training for the Twenty-First Century. Front Vet Sci. 2021; 8:646022. PMC: 8353195. DOI: 10.3389/fvets.2021.646022. View

Morris A, Wu H, Morales C . Barriers to Care in Veterinary Services: Lessons Learned From Low-Income Pet Guardians' Experiences at Private Clinics and Hospitals During COVID-19. Front Vet Sci. 2021; 8:764753. PMC: 8564046. DOI: 10.3389/fvets.2021.764753. View

STIERLIN H, Faigle J . Biotransformation of diclofenac sodium (Voltaren) in animals and in man. II. Quantitative determination of the unchanged drug and principal phenolic metabolites, in urine and bile. Xenobiotica. 1979; 9(10):611-21. DOI: 10.3109/00498257909042328. View

Freedman A, Gronau I, Schweizer R, Ortega-Del Vecchyo D, Han E, Silva P . Genome sequencing highlights the dynamic early history of dogs. PLoS Genet. 2014; 10(1):e1004016. PMC: 3894170. DOI: 10.1371/journal.pgen.1004016. View

10.

Temrikar Z, Golden J, Jonsson C, Meibohm B . Clinical and Translational Pharmacology Considerations for Anti-infectives Approved Under the FDA Animal Rule. Clin Pharmacokinet. 2023; 62(7):943-953. PMC: 10471120. DOI: 10.1007/s40262-023-01267-x. View

11.

Sato M, Manabe N, Hata J, Ishii M, Kamada T, Kusunoki H . Effect of irsogladine maleate on NSAID-induced reduction of gastric mucosal blood flow in anesthetized dogs. Digestion. 2009; 79(2):73-8. DOI: 10.1159/000206823. View

12.

Kogan L, Schoenfeld-Tacher R, Gould L, Hellyer P, Dowers K . Information prescriptions: A tool for veterinary practices. Open Vet J. 2015; 4(2):90-5. PMC: 4629609. View

13.

Van Vertloo L, Terhaar H, Viall A, Allbaugh R . Retrospective evaluation of the incidence of gastrointestinal bleeding in dogs receiving ophthalmic nonsteroidal anti-inflammatory drugs. Vet Ophthalmol. 2023; 26(6):560-564. DOI: 10.1111/vop.13145. View

14.

Hata J, Kamada T, Manabe N, Kusunoki H, Kamino D, Nakao M . Famotidine prevents canine gastric blood flow reduction by NSAIDs. Aliment Pharmacol Ther. 2005; 21 Suppl 2:55-9. DOI: 10.1111/j.1365-2036.2005.02475.x. View

15.

Ng L, Halliwell B, Wong K . Nephrotoxic cell death by diclofenac and meloxicam. Biochem Biophys Res Commun. 2008; 369(3):873-7. DOI: 10.1016/j.bbrc.2008.02.116. View

16.

Vane J, Botting R . Mechanism of action of anti-inflammatory drugs. Scand J Rheumatol Suppl. 1996; 102:9-21. DOI: 10.3109/03009749609097226. View

17.

de Marchi P, Sueur Vieira A, Antunes Ribeiro J, Geraldes S, Rodrigues Ramos P, Melchert A . Use of Nandrolone Decanoate in Treatment of Pure Red Cell Aplasia Secondary to Diclofenac Administration: A Case Report. Top Companion Anim Med. 2017; 32(1):44-47. DOI: 10.1053/j.tcam.2017.05.007. View

18.

Hijos-Mallada G, Sostres C, Gomollon F . NSAIDs, gastrointestinal toxicity and inflammatory bowel disease. Gastroenterol Hepatol. 2021; 45(3):215-222. DOI: 10.1016/j.gastrohep.2021.06.003. View

19.

Selvaraj S, Oh J, Borlak J . An adverse outcome pathway for immune-mediated and allergic hepatitis: a case study with the NSAID diclofenac. Arch Toxicol. 2020; 94(8):2733-2748. PMC: 7395045. DOI: 10.1007/s00204-020-02767-6. View

20.

Keck G, Ibrahim C . Veterinary pharmacovigilance: between regulation and science. J Vet Pharmacol Ther. 2002; 24(6):369-73. DOI: 10.1046/j.1365-2885.2001.00375.x. View